Comparable stake leader
Randal J. Kirk
SEC ownership of PRECIGEN, INC.
Top holders, 13D/G large-stake signals, insider positions, and transaction flow tied to CIK 0001356090.
Disclosed value leader
Randal J. Kirk
Comparable rows
50/50
Latest evidence
30 Jun 2026
- Public ticker
- PGEN on Nasdaq
- Parsed ownership sources
-
3/4/5, 13D/G, and 13F
Source: Parsed SEC ownership filingsUse: Compare filing families carefully
- Largest SEC-reported holder
-
Randal J. Kirk
Ranking: Comparable ownership first, then disclosed value
- Comparable ownership rows
-
50 of 50
Meaning: Rows with safely comparable ownership %
- Latest 13D/G holder
-
Randal J. Kirk
Source: Latest parsed Schedule 13D/G stake
- Latest parsed ownership date
-
30 Jun 2026
Freshness: Most recent filing date in this holder set
- Issuer CIK
- 0001356090
- Issuer location
- Germantown, MD
Ownership snapshot
CIK-linked ownership evidence from parsed SEC filings.
3 signals
Issuer
Names, identifiers, and filing context for this profile.
2 identity fields
Ownership snapshot
Top shareholders of PRECIGEN, INC. (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
Randal J. Kirk
Disclosed value leader
Randal J. Kirk
Comparable rows
50/50
Latest evidence
30 Jun 2026
3/4/5
13D/G
13F
Lead comparable stake: 36%
13D/G row: Randal J. Kirk
Showing 1-8 of 50 holder rows.
Quick read
Randal J. Kirk leads the comparable SEC ownership view at 36%.
50 of 50 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens Randal J. Kirk's linked filing trail.
Comparable ownership
Top 5
Randal J. Kirk
36%
Patient Capital Management, LLC
10%
William H. Miller III
9.2%
Merck KGaA
4.9%
Point72 Asset Management, L.P.
1.9%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-8 of 50 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| Randal J. Kirk |
3/4/5
13D/G
Director, 10%+ Owner
|
36%
from 13D/G
|
$399,586,241
117,527,718 shares
mixed-class rows
|
-$60,808,573 | 26 Mar 2026 |
| Patient Capital Management, LLC |
13D/G
13F
Company
|
10%
|
$150,508,424
36,006,800 shares
|
-$38,525,651 | 31 Dec 2025 |
| William H. Miller III |
13D/G
William H. Miller III Living Trust dated April 17, 2017
|
9.2%
|
$154,936,259
34,051,925 shares
|
$0 | 26 Jun 2025 |
| Merck KGaA |
13D/G
Ares Trading SA
|
4.9%
|
—
17,467,152 shares
|
$0 | 09 Jun 2026 |
| Point72 Asset Management, L.P. |
13F
13D/G
Company
|
1.9%
from 13D/G
|
$7,220,070
1,266,679 shares
|
— | 30 Jun 2026 |
| BlackRock, Inc. |
13F
Company
|
4.9%
|
$97,737,450
17,146,921 shares
|
— | 30 Jun 2026 |
| STATE STREET CORP |
13F
Company
|
3.4%
|
$68,414,051
12,002,465 shares
|
— | 30 Jun 2026 |
| Diametric Capital, LP |
13F
Company
|
2.6%
|
$52,838,578
9,269,926 shares
|
— | 30 Jun 2026 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
Forms 3/4/5 flow
Insider trading overview
Net insider flow leans to selling over the last 12 months. Net value: -$68,749,397.
Buys
$92,957
Insiders: 4
Sells
$68,842,355
Insiders: 7
Net
-$68,749,397
Shares: -17,984,906
Window
Last 12 months
4 rolling buckets
Buy value
Sell value
Shares: 22,627
Shares: 18,007,533
| Window (months) | Buy shares | Sell shares | Buy value | Sell value | Net value |
|---|---|---|---|---|---|
| 0-3 | 3,411 | 1,148,677 | $24,662 | $6,573,691 | -$6,549,030 |
| 3-6 | 0 | 4,772,781 | $0 | $15,750,177 | -$15,750,177 |
| 6-9 | 0 | 2,135,503 | $0 | $8,798,049 | -$8,798,049 |
| 9-12 | 19,216 | 9,950,572 | $68,296 | $37,720,437 | -$37,652,141 |
Reporting owners
Insider holders from Forms 3/4/5
Showing 1-18 of 18 reporting-owner rows connected to PRECIGEN, INC.. Open a relationship link for the CIK-to-CIK filing trail.
Rows
18
Largest Forms 3/4/5 holder
Randal J. Kirk
Net 12M change
-$68,749,397
Latest report
23 Aug 2026
| Name | Relationship | Holdings Value | Past Year Net Change | Change % | Valuation | Report Date |
|---|---|---|---|---|---|---|
| Randal J. Kirk | Director, 10%+ Owner | $399,586,241 | -$60,808,573 | -13% | Mixed | 26 Mar 2026 |
| Ares Trading S.A. | 10%+ Owner | $29,112,484 | Mixed | 12 Oct 2021 | ||
| Helen Sabzevari | President and CEO | $23,420,967 | -$2,562,794 | -9.9% | Mixed | 23 Aug 2026 |
| Fred Hassan | Director | $5,892,952 | Mixed | 13 Mar 2026 | ||
| Steven Frank | Director | $5,813,093 | Mixed | 13 Mar 2026 | ||
| Donald P. Lehr | Chief Legal Officer | $4,609,545 | -$127,011 | -2.7% | Mixed | 23 Aug 2026 |
| Rutul R. Shah | Chief Operating Officer | $3,820,047 | -$1,249,598 | -25% | Mixed | 21 Aug 2026 |
| Cesar L. Alvarez | Director | $3,710,988 | Mixed | 13 Mar 2026 | ||
| James S. Turley | Director | $3,248,876 | Mixed | 13 Mar 2026 | ||
| Vinita D. Gupta | Director | $3,156,967 | Mixed | 13 Mar 2026 | ||
| Nancy H. Agee | Director | $2,360,422 | +$24,662 | +1.1% | Mixed | 21 Aug 2026 |
| Harry Thomasian Jr. | Chief Financial Officer | $1,740,806 | -$1,861,741 | -52% | Mixed | 23 Aug 2026 |
| Phil Tennant | Chief Commercial Officer | $1,180,547 | -$704,251 | -37% | Mixed | 23 Aug 2026 |
| Jeffrey B. Kindler | Director | $957,954 | -$1,460,091 | -60% | Mixed | 13 Mar 2026 |
| Dean J. Mitchell | Director | $844,551 | Mixed | 14 Mar 2024 | ||
| Robert B. Shapiro | Director | $657,116 | Mixed | 09 Mar 2023 | ||
| Jeffrey Thomas Perez | SVP, IP Affairs | $631,632 | Filing P/S | 09 Aug 2024 | ||
| James Vincent Lambert | Ex. Dir. Fin., PGEN Ther. Inc. | $17,422 | Mixed | 10 Jun 2021 |
Recent insider transactions for PRECIGEN, INC.
Showing up to 300 recent insider transactions from the last 12 months.
| Insider | Symbol | Class | Transaction | % | SEC-reported value | SEC-reported price | Shares | Shares owned | Date | Ownership |
|---|---|---|---|---|---|---|---|---|---|---|
| Rutul R. Shah | PGEN | Common Stock | Sale | -3.17% | $115,065 | $7.50 | -15,342 | 468,865 | 25 Aug 2026 | Direct |
| Rutul R. Shah | PGEN | Common Stock | Options Exercise | 3.27% | 15,342 | 484,207 | 25 Aug 2026 | Direct | ||
| Rutul R. Shah | PGEN | Option to Purchase Common Stock (Right to Buy) | Options Exercise | -17.3% | -15,342 | 73,304 | 25 Aug 2026 | Direct | ||
| Phil Tennant | PGEN | Common Stock | Sale | -35.8% | $593,745 | $7.50 | -79,166 | 141,992 | 25 Aug 2026 | Direct |
| Phil Tennant | PGEN | Common Stock | Options Exercise | 55.8% | 79,166 | 221,158 | 25 Aug 2026 | Direct | ||
| Phil Tennant | PGEN | Option to Purchase Common Stock (Right to Buy) | Options Exercise | -39.6% | -79,166 | 120,834 | 25 Aug 2026 | Direct | ||
| Donald P. Lehr | PGEN | Common Stock | Tax liability | -0.33% | -2,488 | 758,181 | 23 Aug 2026 | Direct | ||
| Donald P. Lehr | PGEN | Common Stock | Options Exercise | 0.69% | 5,208 | 760,669 | 23 Aug 2026 | Direct | ||
| Donald P. Lehr | PGEN | Restricted Stock Units | Options Exercise | -8.33% | -5,208 | 57,292 | 23 Aug 2026 | Direct | ||
| Harry Thomasian Jr. | PGEN | Common Stock | Tax liability | -1.37% | -3,577 | 258,249 | 23 Aug 2026 | Direct | ||
| Harry Thomasian Jr. | PGEN | Common Stock | Options Exercise | 2.86% | 7,291 | 261,826 | 23 Aug 2026 | Direct | ||
| Harry Thomasian Jr. | PGEN | Restricted Stock Units | Options Exercise | -8.33% | -7,291 | 80,209 | 23 Aug 2026 | Direct | ||
| Rutul R. Shah | PGEN | Common Stock | Tax liability | -0.77% | -3,647 | 468,865 | 23 Aug 2026 | Direct | ||
| Rutul R. Shah | PGEN | Common Stock | Options Exercise | 1.61% | 7,500 | 472,512 | 23 Aug 2026 | Direct | ||
| Rutul R. Shah | PGEN | Restricted Stock Units | Options Exercise | -11.6% | -7,500 | 57,292 | 23 Aug 2026 | Direct | ||
| Phil Tennant | PGEN | Common Stock | Tax liability | -1.79% | -2,585 | 141,992 | 23 Aug 2026 | Direct | ||
| Phil Tennant | PGEN | Common Stock | Options Exercise | 3.74% | 5,208 | 144,577 | 23 Aug 2026 | Direct | ||
| Phil Tennant | PGEN | Restricted Stock Units | Options Exercise | -8.33% | -5,208 | 57,292 | 23 Aug 2026 | Direct | ||
| Helen Sabzevari | PGEN | Common Stock | Tax liability | -0.27% | -10,184 | 3,779,521 | 23 Aug 2026 | Direct | ||
| Helen Sabzevari | PGEN | Common Stock | Options Exercise | 0.55% | 20,833 | 3,789,705 | 23 Aug 2026 | Direct | ||
| Helen Sabzevari | PGEN | Restricted Stock Units | Options Exercise | -8.33% | -20,833 | 229,167 | 23 Aug 2026 | Direct | ||
| Nancy H. Agee | PGEN | Common Stock | Purchase | 1.12% | $24,662 | $7.23 | 3,411 | 309,187 | 21 Aug 2026 | Direct |
| Rutul R. Shah | PGEN | Common Stock | Sale | -6.94% | $259,935 | $7.50 | -34,658 | 465,012 | 21 Aug 2026 | Direct |
| Rutul R. Shah | PGEN | Common Stock | Options Exercise | 7.45% | 34,658 | 499,670 | 21 Aug 2026 | Direct | ||
| Rutul R. Shah | PGEN | Option to Purchase Common Stock (Right to Buy) | Options Exercise | -28.1% | -34,658 | 88,646 | 21 Aug 2026 | Direct | ||
| Rutul R. Shah | PGEN | Common Stock | Sale | -6.58% | $224,590 | $6.86 | -32,739 | 465,012 | 06 Aug 2026 | Direct |
| Rutul R. Shah | PGEN | Common Stock | Sale | -6.35% | $219,518 | $6.50 | -33,772 | 497,751 | 03 Aug 2026 | Direct |
| Rutul R. Shah | PGEN | Common Stock | Options Exercise | 6.78% | 33,772 | 531,523 | 03 Aug 2026 | Direct | ||
| Rutul R. Shah | PGEN | Option to Purchase Common Stock (Right to Buy) | Options Exercise | -21.5% | -33,772 | 123,304 | 03 Aug 2026 | Direct | ||
| Harry Thomasian Jr. | PGEN | Common Stock | Sale | -28.2% | $606,000 | $6.06 | -100,000 | 254,535 | 31 Jul 2026 | Direct |
| Harry Thomasian Jr. | PGEN | Common Stock | Sale | -32.6% | $948,002 | $5.53 | -171,429 | 354,535 | 01 Jul 2026 | Direct |
| Harry Thomasian Jr. | PGEN | Common Stock | Sale | -5.15% | $165,140 | $5.78 | -28,571 | 525,964 | 29 Jun 2026 | Direct |
| Rutul R. Shah | PGEN | Common Stock | Sale | -7.94% | $251,105 | $5.85 | -42,924 | 497,751 | 29 Jun 2026 | Direct |
| Rutul R. Shah | PGEN | Common Stock | Options Exercise | 8.62% | 42,924 | 540,675 | 29 Jun 2026 | Direct | ||
| Rutul R. Shah | PGEN | Option to Purchase Common Stock (Right to Buy) | Options Exercise | -21.5% | -42,924 | 157,076 | 29 Jun 2026 | Direct | ||
| Helen Sabzevari | PGEN | Common Stock | Sale | -8.43% | $2,042,864 | $5.89 | -346,836 | 3,768,872 | 29 Jun 2026 | Direct |
| Helen Sabzevari | PGEN | Common Stock | Options Exercise | 9.2% | 346,836 | 4,115,708 | 29 Jun 2026 | Direct | ||
| Helen Sabzevari | PGEN | Option to Purchase Common Stock (Right to Buy) | Options Exercise | -41% | -346,836 | 500,164 | 29 Jun 2026 | Direct | ||
| Harry Thomasian Jr. | PGEN | Common Stock | Sale | -7.02% | $182,614 | $4.36 | -41,884 | 554,535 | 28 May 2026 | Direct |
| Phil Tennant | PGEN | Common Stock | Sale | -17.8% | $131,986 | $4.36 | -30,272 | 139,369 | 28 May 2026 | Direct |
| Rutul R. Shah | PGEN | Common Stock | Sale | -7.9% | $186,185 | $4.36 | -42,703 | 497,751 | 28 May 2026 | Direct |
| Donald P. Lehr | PGEN | Common Stock | Sale | -3.71% | $127,011 | $4.36 | -29,131 | 755,461 | 28 May 2026 | Direct |
| Helen Sabzevari | PGEN | Common Stock | Sale | -3.07% | $519,930 | $4.36 | -119,250 | 3,768,872 | 28 May 2026 | Direct |
| Harry Thomasian Jr. | PGEN | Common Stock | Options Exercise | 17.2% | 87,500 | 596,419 | 23 May 2026 | Direct | ||
| Harry Thomasian Jr. | PGEN | Restricted Stock Units | Options Exercise | -50% | -87,500 | 87,500 | 23 May 2026 | Direct | ||
| Phil Tennant | PGEN | Common Stock | Options Exercise | 58.3% | 62,500 | 169,641 | 23 May 2026 | Direct | ||
| Phil Tennant | PGEN | Restricted Stock Units | Options Exercise | -50% | -62,500 | 62,500 | 23 May 2026 | Direct | ||
| Rutul R. Shah | PGEN | Common Stock | Options Exercise | 20% | 90,000 | 540,454 | 23 May 2026 | Direct | ||
| Rutul R. Shah | PGEN | Restricted Stock Units | Options Exercise | -50% | -90,000 | 90,000 | 23 May 2026 | Direct | ||
| Helen Sabzevari | PGEN | Common Stock | Options Exercise | 6.87% | 250,000 | 3,888,122 | 23 May 2026 | Direct |
* marks a reported price that did not pass the local price check.